Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07544303

Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis)

This study will be conducted to evaluate the effects of Quran recital on fatigue and mental well-being in patients with multiple sclerosis.

Hypotheses:

1. Quran recital reduces fatigue in MS patients. 2. Quran recital increases mental well-being in MS patients. The patients will be called by the researcher to ask whether they continue this practice. The control group will continue their routine treatment and care and no additional intervention will be applied. The final test measurements will be made by meeting with the patients in the hospital at the end of the 4th week.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Van Yüzüncü Yıl University Dursun Odabaş Medical Center

Van, 65200, Turkey (Türkiye)

Location status: Recruiting

Location contact

Yavuz Üren, Asst. Prof

CONTACT

About this study

50 patients who meet the inclusion criteria and voluntarily agree to participate in the study will be determined. These patients will be informed about the study and their consent will be obtained. These patients will then be randomized into the Quran recital group and the control group. Personal and contact information of the patients will be recorded and pre-test forms will be applied. The Quran recital group will be asked to listen to the Quran for half an hour with an mp3 player given to them 3 days a week (Monday-Wednesday-Friday) between 21:00-22:00 and this practice will be continued for 4 weeks. The patients will be called by the researcher to ask whether they continue this practice. The control group will continue their routine treatment and care and no additional intervention will be applied. The final test measurements will be made by meeting with the patients in the hospital at the end of the 4th week.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having been diagnosed with Multiple Sclerosis at least 6 months ago
  • Being between the ages of 18-80
  • Agreeing to participate in the research
  • Not having any obstacles to wearing headphones
  • Not having any hearing problems

Exclusion criteria

  • Those with major psychiatric disorders
  • Those with any obstacle to communication

Treatment and study plan

Quran recital

Behavioral

The Quran recital group will be asked to listen to the Quran (Surah Yasin) for half an hour with an mp3 player given to them between 21.00-22.00 three days a week (Monday-Wednesday-Friday) and they will be asked to continue this practice for 4 weeks.

Primary outcomes

  1. Fatigue Impact

    Time frame: 1 mount

    The Fatigue Impact Scale (FIS)

Secondary outcomes

  1. Fatigue Severity Warwick-Edinburgh Mental Well-Being Scale

    Time frame: 1 mount

    The Fatigue Severity Scale (FSS)

Study contacts

Contact information is provided by the study sponsor or research team.

SEVGİ DEMİR ÇAM, Asst. Prof

CONTACT

[email protected]

905073468284

Yavuz Üren, Asst. Prof

CONTACT

[email protected]

905065961050

Sponsors and collaborators

Lead sponsor

Artvin Coruh University

Other

Registry information

Official study title

Evaluation of the Effect of Quran Recitation on Fatigue and Mental Well-Being in MS Patients: A Randomized Controlled Trial

Acronym: MS

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 22, 2026
Registry last updated
Apr 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.